Literature DB >> 28385375

The Society of Thoracic Surgeons Composite Score for Evaluating Esophagectomy for Esophageal Cancer.

.   

Abstract

BACKGROUND: The Society of Thoracic Surgeons (STS) has developed composite quality measures for cardiac surgical procedures and lobectomy for lung cancer. This study sought to develop a composite measure for esophagectomy for esophageal cancer.
METHODS: The STS esophagectomy composite score is derived from two risk-adjusted outcomes: mortality and major complications. General Thoracic Surgery Database data were included from 2012 to 2014, and 95% Bayesian credible intervals were established to determine "star" ratings. STS participants were compared with the National Inpatient Sample as a national benchmark (including non-STS participants).
RESULTS: The study population included 4,321 patients who underwent esophagectomy from 167 participating centers. The operative mortality rate was 3.1% (N = 135), and the major complication rate was 33.1% (N = 1,429). Of the 167 participants, 70 reported an average yearly volume of five or more esophagectomies during the study period. With this threshold, reliability for the composite score was 0.58 (95% credible interval, 0.41 to 0.72). Of these 70 participants, 5 (7.1%) were three star, 63 (90.0%) were two star, and 2 (2.9%) were one star. A majority of STS participants, 58.1% (N = 97), did not have sufficient volume to receive a reliable composite score. Benchmarked to the 2012 National Inpatient Sample cohort, STS General Thoracic Surgery Database participants have comparable discharge mortality rates and shorter postoperative lengths of stay.
CONCLUSIONS: STS has developed a quality measure for esophageal cancer surgical procedures based on a composite score of risk-adjusted operative mortality rates and major complications. The composite rating for esophagectomy has good reliability for programs performing an average of five procedures annually, although almost 60% of participants are not eligible for a star rating because of lower procedure volumes.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28385375     DOI: 10.1016/j.athoracsur.2016.10.027

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma.

Authors:  Tamar B Nobel; Arianna Barbetta; Meier Hsu; Kay See Tan; Smita Sihag; Manjit S Bains; David R Jones; Daniela Molena
Journal:  J Am Coll Surg       Date:  2019-05-17       Impact factor: 6.113

Review 2.  Blazing new trails: initial efforts to create a joint Society of Thoracic Surgeons-European Society of Thoracic Surgeons (STS-ESTS) dataset.

Authors:  Christopher W Seder
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Author's response to invited commentary "a perspective on the Society of Thoracic Surgeons Composite Score for evaluating esophagectomy for esophageal cancer".

Authors:  Andrew C Chang
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 4.  Regionalization of esophagectomy: where are we now?

Authors:  James M Clark; Daniel J Boffa; Robert A Meguid; Lisa M Brown; David T Cooke
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  A perspective on the Society of Thoracic Surgeons Composite Score for evaluating esophagectomy for esophageal cancer.

Authors:  Shuyin Liang; James D Luketich; Inderpal S Sarkaria
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 6.  Surveillance versus esophagectomy in esophageal cancer patients with a clinical complete response after induction chemoradiation.

Authors:  Tara R Semenkovich; Bryan F Meyers
Journal:  Ann Transl Med       Date:  2018-02

7.  Trends in Treatment of T1N0 Esophageal Cancer.

Authors:  Tara R Semenkovich; Jessica L Hudson; Melanie Subramanian; Daniel K Mullady; Bryan F Meyers; Varun Puri; Benjamin D Kozower
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

8.  Outcomes for endoscopic submucosal dissection of pathologically staged T1b esophageal cancer: a multicenter study.

Authors:  Abel Joseph; Peter V Draganov; Fauze Maluf-Filho; Hiroyuki Aihara; Norio Fukami; Neil R Sharma; Amitabh Chak; Dennis Yang; Salmaan Jawaid; John Dumot; Omar Alaber; Tiffany Chua; Rituraj Singh; Lady Katherine Mejia-Perez; Ruishen Lyu; Xuefeng Zhang; Suneel Kamath; Sunguk Jang; Sudish Murthy; John Vargo; Amit Bhatt
Journal:  Gastrointest Endosc       Date:  2022-02-22       Impact factor: 10.396

9.  Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer.

Authors:  Smita Sihag; Geoffrey Y Ku; Kay See Tan; Samuel Nussenzweig; Abraham Wu; Yelena Y Janjigian; David R Jones; Daniela Molena
Journal:  J Thorac Cardiovasc Surg       Date:  2020-12-17       Impact factor: 5.209

10.  Textbook outcome for esophageal cancer surgery: an international consensus-based update of a quality measure.

Authors:  Marianne C Kalff; Mark I van Berge Henegouwen; Suzanne S Gisbertz
Journal:  Dis Esophagus       Date:  2021-07-12       Impact factor: 3.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.